International Online Medical Council (IOMC)

Research Article

Pages: 1 - 11

Outcomes of a Switch to Fingolimod to Treat Relapsing Multiple Sclerosis: A Patient Subgroup Post Hoc Analysis

Mark Gudesblatt, Neetu Agashivala, Simrat Randhawa, Stan Li, Luigi Barbato and Barry Singer

Research Article

Pages: 1 - 7

Association of Multiple Sclerosis Related Cognitive Impairment with an MRIDerived Composite Score

Flavia Nelson, Aziz H. Poonawalla, Sushmita Datta, Rosa C. Banuelos, Mohammad H. Rahbar, Francisco Perez, Jerry S. Wolinsky and Ponnada A. Narayana

Case Report

Pages: 1 - 3

Neurological Deterioration in a PML-HIV Patient in the Absence of Immune Reconstitution Inflammatory Syndrome

Valerie Arias M, Sarah E. Martin, John Farrell and Jorge C Kattah

Review Article

Pages: 1 - 9

New and Old Concepts and Strategies for Progressive Multifocal Leukoencephalopathy

Isabel Moreira and Monica Marta

Research Article

Pages: 1 - 6

Anger, Quality of Life and Mood in Multiple Sclerosis

Christianne M. Laing, Louise H. Phillips, Clare. L. Cooper, Judith A. Hosie and Fiona Summers

Commentry

Pages: 1 - 2

Advances in Flow Cytometry Investigation of Cannbinoid CB2 Receptor Agonists in Multiple Sclerosis: Commentary

Maurizio Bifulco and Anna Maria Malfitano

Research Article

Pages: 1 - 7

Impairment of Visual Cognition in Progressive Multiple Sclerosis

Thomas H. Bak, Siddharthan Chandran and Peter Connick

Review Article

Pages: 1 - 11

Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis

Sushmita Sinha and Nitin J. Karandikar

Research Article

Pages: 1 - 10

Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal

Ahmed H Badawi, Paul Kiptoo and Teruna J Siahaan

Review Article

Pages: 1 - 4

Mitochondrial DNA Mutation in Microglia Can Be Treated by SCNT Cloning and Not by Reprogramming of Olfactory Ensheathing Cells in the Multiple Sclerosis Treatment

Abdul Mannan Baig

Research Article

Pages: 1 - 7

Effects of Exercise Intensity in Experimental Autoimmune Encephalomyelitis

Wens I, Broekmans T, Hendriks JJA, Savelberg HH, Hesselink MK and Eijnde BO

Journal of Multiple Sclerosis

Volume 2, Issue 1, 2015

Outcomes of a Switch to Fingolimod to Treat Relapsing Multiple Sclerosis: A Patient Subgroup Post Hoc Analysis

Association of Multiple Sclerosis Related Cognitive Impairment with an MRIDerived Composite Score

Neurological Deterioration in a PML-HIV Patient in the Absence of Immune Reconstitution Inflammatory Syndrome

New and Old Concepts and Strategies for Progressive Multifocal Leukoencephalopathy

Anger, Quality of Life and Mood in Multiple Sclerosis

Advances in Flow Cytometry Investigation of Cannbinoid CB2 Receptor Agonists in Multiple Sclerosis: Commentary

Impairment of Visual Cognition in Progressive Multiple Sclerosis

Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis

Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal

Mitochondrial DNA Mutation in Microglia Can Be Treated by SCNT Cloning and Not by Reprogramming of Olfactory Ensheathing Cells in the Multiple Sclerosis Treatment

Effects of Exercise Intensity in Experimental Autoimmune Encephalomyelitis

Journal Highlights

Journal Flyer

+44-73-6204-9920